The present invention relates to stable aqueous oral formulation of bisphosphonic acid or its pharmaceutically acceptable salts. One system includes a transceiver configured to communicate with a systems management console, capture device for capturing environmental inputs, memory storing code comprising an augmented reality module, and a processor. An elongate end cap fitted in the first panel member defines a cavity for receiving an end seal for sealing engagement with a mine surface. A network record collector observes the traffic throughout the network in response to the repeated instances of the transaction executed by the robotic transaction playback client.